Screener
Acadia Pharmaceuticals ACAD Gross Profit
Gross Profit at other companies
Other financials
Where this comes from
Calculated from Acadia Pharmaceuticals’s reported figures.
The source filing: Acadia Pharmaceuticals’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 4, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333243
FAQ
- What is Acadia Pharmaceuticals's gross profit?
- Acadia Pharmaceuticals (ACAD) reported gross profit of $279.64M in Q2 2026.
- How has Acadia Pharmaceuticals's gross profit changed year-over-year?
- Acadia Pharmaceuticals's gross profit increased by 14.7% year-over-year, from $243.83M to $279.64M.
- What is the long-term trend for Acadia Pharmaceuticals's gross profit?
- Over 4 years (2021 to 2025), Acadia Pharmaceuticals's gross profit has grown at a 20.6% compound annual growth rate (CAGR), from $465M to $982.51M.
- What does gross profit mean?
- Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.
Ask your AI about Acadia Pharmaceuticals's gross profit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude